Back to Search
Start Over
Reply to the letter to the editor ‘Flaws in the trial design of IFCT-0802’ by Gyawali et al
- Source :
- Annals of Oncology, Annals of Oncology, Elsevier, 2015, 26 (10), pp.2199.1-2199. ⟨10.1093/annonc/mdv292⟩
- Publication Year :
- 2015
- Publisher :
- HAL CCSD, 2015.
-
Abstract
- International audience
- Subjects :
- Male
medicine.medical_specialty
Lung Neoplasms
Letter to the editor
Bevacizumab
Angiogenesis Inhibitors
[SDV.CAN]Life Sciences [q-bio]/Cancer
03 medical and health sciences
0302 clinical medicine
Antineoplastic Combined Chemotherapy Protocols
medicine
Humans
030212 general & internal medicine
ComputingMilieux_MISCELLANEOUS
business.industry
General surgery
Hematology
Small Cell Lung Carcinoma
Surgery
Oncology
030220 oncology & carcinogenesis
Female
business
medicine.drug
Subjects
Details
- Language :
- English
- ISSN :
- 09237534 and 15698041
- Database :
- OpenAIRE
- Journal :
- Annals of Oncology, Annals of Oncology, Elsevier, 2015, 26 (10), pp.2199.1-2199. ⟨10.1093/annonc/mdv292⟩
- Accession number :
- edsair.doi.dedup.....99ccdc4b6cd9e0d7072fdf568f5ea2aa